Drugs / PF-06751979
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03126721 | Apr → Jul 2017 | — | Pfizer | Completed | No outcome recorded |
| Phase 1 | NCT02793232 | Jun 2016 → Jan 2017 | — | Pfizer | Completed | No outcome recorded |
| Phase 1 | NCT02509117 | Jul 2015 → Jul 2016 | — | Pfizer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-06751979 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03126721 ↗ |
| Route | Oral | “following oral doses” NCT02509117 ↗ |